FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence.
about
Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.
P2860
FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence.
@en
FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence.
@nl
type
label
FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence.
@en
FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence.
@nl
prefLabel
FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence.
@en
FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence.
@nl
P2093
P2860
P356
P1476
FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence.
@en
P2093
Ana Blanca
Antonio Lopez-Beltran
Carlos Reymundo
Jose Alvarez
Liang Cheng
Maria J Requena
Maria R Raspollini
P2860
P304
P356
10.2217/BMM.15.120
P577
2016-02-09T00:00:00Z